ALCBX
Price
$13.10
Change
+$0.03 (+0.23%)
Updated
Oct 17 closing price
Net Assets
12.75M
RLEFX
Price
$38.98
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.37B
Interact to see
Advertisement

ALCBX vs RLEFX

Header iconALCBX vs RLEFX Comparison
Open Charts ALCBX vs RLEFXBanner chart's image
ALPS/Smith Balanced Opportunity C
Price$13.10
Change+$0.03 (+0.23%)
VolumeN/A
Net Assets12.75M
American Funds American Balanced R5E
Price$38.98
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.37B
ALCBX vs RLEFX Comparison Chart in %
View a ticker or compare two or three
VS
ALCBX vs. RLEFX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALCBX is a Buy and RLEFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 265B vs. ALCBX (12.8M). RLEFX pays higher dividends than ALCBX: RLEFX (1.92) vs ALCBX (1.03). ALCBX was incepted earlier than RLEFX: ALCBX (5 years) vs RLEFX (10 years). ALCBX (3.33) is less costly to investors than RLEFX (0.39). ALCBX is a more actively managed with annual turnover of: 131.00 vs. RLEFX (44.00). RLEFX has a lower initial minimum investment than ALCBX: RLEFX (250) vs ALCBX (2500). RLEFX annual gain was more profitable for investors over the last year : 8.94 vs. ALCBX (-1.45). RLEFX return over 5 years is better than : 43.26 vs. ALCBX (33.01).
ALCBXRLEFXALCBX / RLEFX
Total Expense Ratio1.850.39474%
Annual Report Gross Expense Ratio3.330.39854%
Fund Existence5 years10 years-
Gain YTD9.16014.81962%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets12.8M265B0%
Annual Yield % from dividends1.031.9254%
Returns for 1 year-1.458.94-16%
Returns for 3 years35.2851.3969%
Returns for 5 years33.0143.2676%
Returns for 10 years15.96N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COEP15.380.38
+2.53%
Coeptis Therapeutics Holdings Inc
STC69.760.91
+1.32%
Stewart Information Services Corp
ATMVU22.00N/A
N/A
AlphaVest Acquisition Corp
BBIO54.92-0.11
-0.20%
BridgeBio Pharma
SRTA4.99-0.09
-1.77%
Strata Critical Medical Inc